Long term debt...is manageable without selling off major assets until 2019, by then debt will be reconsolidated. VRX just sold rights to 1 drug for 1/2 of its potential market for $1B + 115M for reaching milestones. That was 1 of its 100+ potential sales for profit. Debt for 2016 is basically paid off. 3 new drugs waiting for approvals with huge upside as cash cows. Why is there a panic to sell assets? I think this giant is about to grow wings!!